An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen

International Archives of Allergy and Immunology

Volumn 135, Issue 2, 2004, Pages 117-131

  Norris Reinero, Carol R ^a,c   Decile, Kendra C ^a   Berghaus, Roy D ^a   Williams, Kurt J ^b   Leutenegger, Christian M ^a   Walby, William F ^a   Schelegle, Edward S ^a   Hyde, Dallas M ^a   Gershwin, Laurel J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Airway hyperreactivity; Airway remodeling; Allergy; Animal model; Chronic allergen challenge; Feline; IgE

Indexed keywords

ALLERGEN; BERMUDA GRASS ALLERGEN; CYTOKINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CAT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HELPER CELL; HISTOLOGY; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGY; IMMUNOPATHOLOGY; NONHUMAN; PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIZATION; SKIN TEST; TRACHEOBRONCHIAL TOILET;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CATS; CYNODON; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PYROGLYPHIDAE;

EID: 5644227352     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080654     Document Type: Article

References (37)

1. Tattersfield A, Knox A, Britton J, Hall I: Asthma. Lancet 2002;360:1313-1322.
2. Redd S: Asthma in the United States: Burden and Current Theories. Environ Health Perspect 2002;110(suppl 4):557-560.
3. Padrid P: Animal models of asthma; in Liggett SB, Meyers DA (eds): The Genetics of Asthma: Lung Biology in Health and Disease. New York, Dekker, 1995, pp 211-233.
4. Schelegle E, Gershwin L, Miller L, Fanucchi M: Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol 2001;158:333-341.
5. Padrid P, Snook S, Finucane T: Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995;151:184-193.
6. Moise N, Weidenkeller D, Yeager A: Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 1989;194:1467-1473.
7. Guidelines for the Diagnosis and Management of Asthma, ed 2. Bethesda, National Institutes of Health, 1997, pp 1-153.
8. Dye J, McKiernan B, Rozanski E, Hoffmann W: Bronchopulmonary disease in the cat: Historical, physical, radiographic, clinicopathologic, and pulmonary function evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996;10:385-400.
9. Talbott M, Strausser H: Increase in serum IgE levels of ovalbumin-sensitized cats and the detection of elastase and collagenase activities in secretions of sensitized feline alveolar macrophages challenged in vitro. Int Arch Allergy Appl Immunol 1977;54:198-204.
10. Norris C, Gershwin L, Decile K, Berghaus L: Cysteinyl leukotrienes in urine and bronchoalveolar lavage fluid in an experimental model of feline asthma. Am J Vet Res 2003;64:1449-1453.
11. Norris C, Decile K, Byerly J, Berghaus R, Schelegle E, Hyde D, Gershwin L: Production of polyclonal antisera against feline immunoglobulin E and its use in an ELISA in cats with experimentally induced asthma. Vet Immunol Immunopathol 2003;96:149-157.
12. Norris C, Byerly J, Decile K, Berghaus R, Walby W, Schelegle E, Hyde D, Gershwin L: Allergen-specific IgG and IgA in serum and bronchoalveolar lavage fluid in a model of experimental feline asthma. Vet Immunol Immunopathol 2003;96:119-127.
13. Foley J, Rand C, Leutenegger C: Inflammation and changes in cytokine levels in neurological feline infectious peritonitis. J Feline Med Surg 2003;5:313-322.
14. Leutenegger C, Mislin C, Sigrist B, Ehrengruber M, Hofmann-Lehmann R, Lutz H: Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet Immunol Immunopathol 1999;71:291-305.
15. Tournoy K, Kips J, Schou C, Pauwels R: Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 2000;30:79-85.
16. Cookson W: The alliance of genes and environment in asthma and allergy. Nature 1999;402S:B5-B11.
17. Kumar R, Foster P: Murine model of chronic human asthma. Immunol Cell Biol 2001;79:141-144.
18. St George J: Cell populations and structurefunction relationships of cells in the airways; in Grardner D, Crapo J, Massaro J (eds): Toxicology of the Lung. New York, Raven Press, 1988, pp 71-101.
19. Kumar R, Foster P: Modeling allergic asthma in mice: Pitfalls and opportunities. Am J Respir Cell Mol Biol 2002;27:267-272.
20. Nilsson L, Gruber C, Granstrom M, Bjorksten B, Kjellman N: Pertussis IgE and atopic disease. Allergy 1998;53:1195-1201.
21. Dong W, Selgrade M, Gilmour M: Systemic administration of Bordetella pertussis enhances pulmonary sensitization to house dust mite in juvenile rats. Toxicol Sci 2003;72:113-121.
22. Djurup R: The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy 1985;40:469-486.
23. Arnaboldi P, Metzger D: The role of IgA in allergic lung inflammation. Keystone Symposia: Rethinking the Pathogenesis of Asthma, Santa Fe, 2002, p 47.
24. Bottcher M, Haggstrom P, Bjorksten B, Jenmalm M: Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy 2002;32:1293-1298.
25. Van der Zee J, Aalberse R: The role of IgG in immediate-type hypersensitivity. Eur Respir J 1991;4(suppl 13):91s-96s.
26. Cohn L, Ray A: T-helper type 2 cell-directed therapy for asthma. Pharmacol Ther 2000;88:187-196.
27. Spicuzza L, Polosa R: The role of adenosine as a novel bronchoprovocant in asthma. Curr Opin Immunol 2003;3:65-69.
28. Holgate S: The epidemic of allergy and asthma. Nature 1999;402S:B2-B4.
29. Van Rijt L, Lambrecht B: Role of dendritic cells and Th2 lymphocytes in asthma: Lessons from eosinophilic airway inflammation in the mouse. Microsc Res Tech 2001;53:256-272.
30. van Rensen E, Stirling R, Scheerens J, Staples K, Sterk P, Barnes P, Chung K: Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax 2001;56:935-940.
31. Leckie M, ten Brinke A, Khan J, Diamant Z, O'Connor B, Walls C: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
32. Buttner C, Lun A, Splettstoesser T, Kunkel G, Renz H: Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003;21:799-803.
33. Pauwels R, Brusselle G, Kips J: Cytokine manipulation in animal models of asthma. Am J Respir Crit Care Med 1997;156:S78-S81.
34. Foster P, Ming Y, Matthei K, Young I, Temelkovski J, Kumar R: Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab Invest 2000;80:655-662.
35. Davies D, Wicks J, Powell R, Puddicombe S, Holgate S: Airway remodeling in asthma: New insights. J Allergy Clin Immunol 2003;111:215-225.
36. Hamid Q: Images in allergy and immunology. J Allergy Clin Immunol 2003;111:431-432.
37. Fernandes D, Xu K, Stewart A: Anti-remodeling drugs for the treatment of asthma: Requirement for animal models of airway wall remodelling. Clin Exp Pharmacol Physiol 2001;28:619-629.